In the healthcare industry, anti-obesity medications like Ozempic, Wegovy, Mounjaro, and Zepbound are making waves. To provide a deeper understanding of these medicines, we have created a series of episodes featuring experts in the field.
Our first guest is Carolyn Jasik, MD, Chief Medical Officer at Omada Health. She discusses the science of satiety and shares insights from obesity-focused physicians. Additionally, she explores the lifestyle implications for patients who use these medications. This series aims to explore what anti-obesity medications are, where they are headed, and the challenges that must be addressed along the way.
